15hon MSN
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...
With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech ...
A first of its kind surgery to help people with a specific type of heart failure is going through clinical trials at Providence St. Vincent’s.
3don MSN
This is just the new way of consuming nicotine,” a vape shop owner in West Campus says of continuing to sell flavored vapes.
The Outsourcing Facilities Association is appealing a ruling that rejected their request for an injunction against the FDA’s ...
1d
News Medical on MSNHow the FDA opens the door to risky chemicals in America's food supplyJoseph Shea, who sells athletic wear in Myrtle Beach, South Carolina, wonders and worries about the food he eats.
An Australian man in his forties has become the first person in the world to leave hospital with an artificial heart made of ...
FDA-approved drugs are also often patented and subject to various laws regarding exclusivity for a given manufacturer. At the ...
Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.
It’s been just six months since Zevra Therapeutics scored an FD | Niemann-Pick disease type C therapy Miplyffa became ...
Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAP Clears the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results